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Indirect  evidence has  implicated the  coagulation system  in  the  pathogenesis of 
cell-mediated hypersensitivity. Thus, anticoagulants have been  shown to inhibit the 
expression of a variety of delayed-type reactions in vivo in animals including classic 
tuberculin skin hypersensitivity (1-5) and allergic contact  dermatitis (2),  the  ocular 
reaction  to  tuberculin  (6),  and  the  antigen-induced  maerophage  disappearance 
reaction (1, 7). Moreover, a variety of agents that interfere with different steps in  the 
clotting sequence has each been effective in suppressing delayed reactivity (1,  2, 4,  5). 
In studies with one such agent, heparin, suppression occurred under conditions that 
did not measurably inhibit the complement system (1, 2), the competence of sensitized 
lymphocytes to  transfer  cell-mediated hypersensitivity passively (2),  or  the  anam- 
nestic antibody response (2). Despite these data there has been reluctance to accept 
a  role for the coagulation system in the expression of delayed hypersensitivity, and, 
in fact, no direct evidence has been presented for activation of clotting in the evolution 
of these reactions. 
Our  interest in  this  problem  stems  from  the  recent  observation  that  sub- 
stantial amounts of a fibrin-like material accumulate in the dermis in lesions of 
allergic contact dermatitis (8).  We have pursued this observation with  fluores- 
cent antibody methods and here demonstrate that fibrin deposition is a  prom- 
inent  and  consistent  feature  of  both  allergic  contact  dermatitis  and  classic 
delayed hypersensitivity skin reactions in man. 
Materials and Methods 
Subjects, Immunizations, and Skin Tests.--A  total of 43 adult volunteers participated in 
this study and were divided into three experimental groups: 
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(a) 21 male volunteers, ages 18-51 yr, were sensitized to dinitrochlorobenzene (DNCB) 1 
by application of 0.1 ml of a  10% acetone solution to the volar surface of the forearm. 12-14 
days later contact reactions were elicited by application of 25 #l of a  0.1  or 0.2%  DNCB 
solution in acetone or methyl Cellosolve  (Union Carbide Corp.,  New  York)  to  the lateral 
aspect of the upper arms. As many as six separate test sites were applied to facilitate sequential 
biopsy of undisturbed lesions. Reactions were read and biopsied at various intervals from 4 h 
to 13 days. In addition, each subject received a  skin test application at the time of sensitiza- 
tion. This reaction was invariably negative clinically and was biopsied at 48 h, well before the 
onset of active immunity, as a  control. 
(b) Naturally acquired contact reactivity to various environmental allergens was studied 
in  12 male and female outpatients, ages 17-56 yr, of Dr. Normand Olivier. These patients 
had symptomatic contact dermatitis to a variety of allergens but were otherwise healthy and 
on no known medication at the time of testing. Allergens included nickel, 4; formaldehyde, 
2;  1,4-benzenediamine, 2; kerosine,  1; lanolin,  1; epoxy,  1; and rubber, 1. All were applied 
as patch tests in the standard concentrations recommended by Fisher (9).  Patch tests were 
removed at 48 h and were read and biopsied at 72 h. 
(c)  14 male volunteers, ages 20-49 yr, including four who also participated in the DNCB 
study, were tested intradermally with a battery of skin test antigens including old tuberculin 
(OT)  (1:1000),  Candida  albicans  (1:1000),  streptokinase  (5  U)/streptodornase  (1.25  U) 
(SK/SD), and mumps (0.1  mg). Tests were read at 4, 24, and 48 h. Biopsies were taken at 
48 h  from 20 clinically positive reactions  (>I0  mm  erythema and  induration), from five 
negative intradermal test sites, from four control sites injected with isotonic saline, and from 
seven untreated  control sites. 
Biopsy and Processing  of Tissue for Microscopic  Examinallon.--Tissue  from a  total of 111 
(83 experimental and 28 control) biopsies was obtained with a 4 mm punch using Xylocaine 
field anesthesia (Astra Pharmaceutical Products,  Inc., Worcester, Mass.).  In this technique 
Xylocaine was injected intradermally around and subcutaneously below the site to be studied 
but never directly into the biopsied tissue. Hence, artifacts due to needle trauma were avoided. 
One half of each biopsy was fixed for 5 h in a mixture of paraformaldehyde-glutaraldehyde and 
was processed in Epon for the preparation of 1 #m, Giemsa-stained sections for light micros- 
copy (8). 
lmmunofluorescence.--The  other half of each biopsy was embedded in 7.5~o  gelatin and 
frozen in a  dry ice-acetone slurry. Cryostat sections were washed 15 min in three changes of 
0.15 M  NaC1-0.01  M  sodium phosphate, pH 7.3  (PBS), and stained for 30 min with mono- 
specific  fluoresceinated goat or rabbit antisera to human flbrinogen/fibrin (Fib), IgG, IgM, 
IgA,  IgE,  /31c//31A  (C'3), and  albumin  (HSA)  (Cappel  Laboratories,  Downingtown,  Pa.) 
diluted  1:4 or 1:8  (10).  After washing in PBS, sections were mounted in Elvanol (E.  I. du 
Pont de Nemours and Co., Wilminton, Del.)  (11) and examined in a Zeiss dark-field fluores- 
cence microscope  (Carl Zeiss, Inc., New York)  equipped with a  UG3 excitor filter and a  44 
barrier filter to provide optimal color contrast between the green fluorescence of fluoresceln 
and the blue autofluorescence of the dermal elastic fibers. The extent and overall intensity of 
Fib staining was graded 0 to 4+. Small but definite focal deposits were scored 4-. Intermediate 
deposits were scored 1+ or 2+, and extensive, intense deposits 3+  or 4+. The activity and 
specificity of the fluoresceinated antisera were confirmed by double gel diffusion, immuno- 
electrophoresis, and inhibition by unlabeled specific  antisera. Further, a  washed fibrin clot, 
made from bovine thrombin-clotted human fibrinogen (Miles Laboratories,  Inc., Kankakee, 
I11.), completely absorbed  the specific  activity from  the rabbit anti-Fib antiserum but did 
not diminish the staining capacity of anti-IgG. 
Because antifibrinogen antibodies have specificity for fibrinogen, fibrin, and certain large 
fibrinogen fragments (12), the antigens detected with this antiserum will be collectively termed 
1 Abbreviations  used  in  this  paper:  DNCB,  dinitrocblorobenzene; Fib,  fibrinogen/fibrin; 
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Fib, even though, as discussed below, fibrillar deposits in tissue that bind this antiserum cer- 
tainly represent  fibrin. 
RESULTS 
Gross and Light Microscopic Appearance.---The delayed reactions elicited with 
intradermal injections of protein antigens consisted of erythematous, indurated 
lesions that first became visible after a null period of 6-12 h  and that achieved 
maximal intensity at 48 h. The reactions of allergic contact dermatitis exhibited 
less  induration, were  not  maximal before  72  h,  and  were  characterized  by 
epidermal changes  that  included edema and vesiculation. In four of five in- 
stances, skin test with mumps virus elicited an early response of erythema and 
swelling maximal at 4 h  that then receded by 8 h  and that was followed sub- 
sequently by a  typical delayed reaction. None of the  other  antigens studied 
produced this bimodal pattern of reactivity. 
As studied in 1 ~m light microscopic sections, all lesions were typical of de- 
layed reactions and were characterized by perivascular accumulations of mono- 
nuclear cells  that  extended  into  the  intervascular zones  and  infiltrated the 
epidermis as well (Fig. 1). The infiltrate of contact dermatitis was confined to 
the papillary and the  superficial reticular dermis, in contrast to intradermal 
reactions to protein antigens in which the deeper layers of the dermis and some- 
times the subcutis were involved as well. In addition, reactions of both types 
had prominent, loose, reticular deposits of fibrillar, fibrin-like material in the 
intervascular regions of the reticular dermis (Figs. 1 and 3). These were asso- 
ciated with collagen bundles and elastic fibers but  not  with  infiltrating cells 
and spared both the perivascular cell accumulations and the vessels themselves. 
Photomicrographs of light microscopic and fluorescent antibody preparations  of allergic 
contact  dermatitis  reactions to DNCB. 
FIG. 1. Low-power field from a  72 h reaction. Mononuclear cells form cuffs about small 
veins and venules and are scattered in the intervascular zones. Fib deposits (arrows)  are located 
primarily in the intervascular portion of the upper reticular  dermis, but focal patches are 
seen deeper in the reticular dermis as well. X  110. 
Fro. 2, Fib deposits as demonstrated by fluorescein-conjugated,  rabbit antihuman fibrino- 
gen/fibrin in a 24 h reaction to DNCB photographed at comparable magnification to Fig. 1. 
Epid, epidermis; PD, papillary dermis; v, negatively staining vessel with mononuclear cell 
cuff at junction between papillary and reticular dermis; Fib, fibrinogen/fibrin in upper reti- 
cular dermis; RD, midreticular dermis. Fib is deposited primarily in the upper reticular dermis 
but focal deposits are detected in the papillary dermis as well as deeper in the reticular dermis. 
FIG, 3.  High magnification photomicrograph illustrating  morphology of Fib deposits in 
the upper reticular dermis of a 24 h reaction to DNCB. Fib is arranged as a loose meshwork 
interlacing between collagen bundles and forms striking associations with elastic fibers (E) 
that in some instances are coated with Fib. Scattered mononuclear cells are present but do 
not exhibit close associations with the Fib deposits. X  1,000. 
Fro. 4. High magnification photomicrograph of a 72 h DNCB reaction stained with fluo- 
rescein-conjugated antihuman fibrinogen/fibrin for  comparison with  Fig. 3.  Note  fibrillar 
appearance of Fib meshwork. Two elastic fibers (E)  exhibited blue autofluorescence but no 
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Similar  deposits  were  sometimes  observed  in  the  papillary  dermis  of  severe 
contact  reactions  but  were  not seen in this location in skin tests with protein 
antigens. Features of Arthus reactivity, such as vascular thrombosis, vasculitis, 
gross hemorrhage, or extensive neutrophil exudation, were not observed in any 
of these reactions. 
Immuno~uorescence:  Fibrinogen/Fibrin  (Fib).--Fully  developed  delayed  re- 
actions elicited with various contact allergens and protein antigens were char- 
acterized by extensive dermal deposits of Fib  (Tables I  and II,  Figs.  2  and 4). 
These  intensely staining  deposits  often  appeared  amorphous  under  low  mag- 
nifications. However,  under higher power they were clearly seen to consist of a 
delicate fibriilar meshwork interspersed between  collagen  bundles and coating 
elastic fibers  (Fig.  4).  Fib was most  abundant  in the intervascular portions of 
the  superficial  reticular  dermis  but  characteristically  spared  the  perivascular 
regions,  which contained the highest density of infiltrating cells  (Fig.  2).  With 
rare exceptions  (see below),  Fib was not seen in blood vessel walls. 
Although  both  allergic  contact  dermatitis  and  delayed  reactions  to  protein 
antigens were  characterized  by prominent  accumulations  of  Fib  in  the upper 
TABLE  I 
Fib Distribution  in Allergic  Contact Dermatitis  Reactions  to DNCB and Environmental  Contact 
Allergens  at Various  Times after Skin Test as Detected by [mmunofluorescence 
No. of  Mean  Upper reticular dermis§  Papillary dermis§ 
Skin test*  subjects  clinical 
score~  0  ±  1+/2+  3+/4+  0  ±  12-/2+  3+/4+ 
I.  DNCB 
(A)  Sensitized 
4 h  5  0  2  3  --  --  5  --  --  -- 
8h  7  0,3  3  3  1  --  4  3  --  -- 
e/el, 4 
24 h  13  ei/eiv  1  2  3  7  2  1  6  4 
48 h  5  ely  -  --  --  5  --  --  3  2 
72 h  8  eiv  -  --  2  6  1  1  6  - 
6 days  5  eiv  -  --  3  2  3  --  1  1 
11-13 days  8  e/el  2  1  .5  --  2  4  2  -- 
(B)  Unsensitized 
8h  3  0  3  --  --  --  3  --  --  -- 
48h  9  0  9  --  --  --  9  --  --  -- 
II.  Environmental 
allergens 
(combined) 
72 h  12  ei/eiv  2  3  4  3  3  .5  3  1 
* Conditions of skin test are recorded in Materials and Methods. 
:~ Reactions were  scored  grossly  as  follows:  0,  no  reaction;  e,  erythema; i,  induration; 
v, vesiculation. 
§ Extent  of  staining after  reaction  with  fluoresceinated  rabbit antihuman fibrinogen/ 
fibrin. 0, negative; 4-,  small, focal deposits only; 1+/2+,  deposits of intermediate extent; 
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TABLE  II 
Fib Distribution  in 48-h  Ddayed  Hypersensitivity  Reactions  after  Intradermal  Challenge with 
Various Antigens as Detecled by  Immunofluorescence 
Skin test* 
No. of  Mean  Reticular dermis§  Papillary dermis§ 
sub-  clinical 
jects  scoreit  0  4-  1+/2+  3+/4+  0  4-  1+/2+  3+/4+ 
OT  5  18  ++  --  --  2  3  2  2  1  -- 
Candida  7  17  ++  --  --  4  3  6  1  --  -- 
SK/SD  3  22  ++  --  --  1  2  1  1  1  -- 
Mumps  5  16  ++  --  --  3  2  4  1  --  -- 
Negative tests]l  5  6  +/++  3  --  2  --  5  --  --  -- 
Saline  4  0  4  --  --  --  4  --  -  -- 
Normal  skin  7  0  7  --  --  --  7  --  --  - 
* Conditions of skin test are recorded in Materials and Methods. 
:~ Reactions were scored as diameter of erythema  (millimeters) and degree of induration 
(0 to +++). 
§ Extent of  staining  after  reaction  with  fluoresceinated rabbit antihuman fibrinogen/ 
fibrin. Scoring same as in Table I. 
I[ Negative 48-h skin reactions (< 10 mm erythema and induration)  to OT (2), SK/SD 
(1) and mumps (2). 
reticular dermis, certain differences were noted with regard to the distribution 
of Fib elsewhere in these two types of reactions. In contact dermatitis Fib was 
frequently present in the papillary dermis (42 of 63 samples), but in only 1 of 
63  biopsies  were  Fib  deposits  more  extensive in  the  papillary  than  in  the 
reticular dermis. In addition, focal fibrillar deposits of Fib were noted in epi- 
dermal  vesicles.  By  contrast,  in  delayed  reactions elicited with  intradermal 
injections of protein antigens, Fib was less commonly present in the papillary 
dermis (focal deposits were found in 7 of 20 samples); however, patchy deposits 
of Fib were present deeper in the reticular dermis and these extended into the 
subcutis as well. Thus, in both types of lesion Fib was deposited in relation to 
areas of cellular infiltration but at the same time exhibited no close association 
with the infiltrating cells themselves (Fig. 5). 
Fib deposits were a  consistent feature of delayed reactions in man, and no 
significant differences  in  the  amount  of  deposition could  be  related  to  the 
particular allergen or antigen employed (Tables I  and II). Thus, Fib was found 
in the reticular dermis in 18, and in the papillary dermis in 16, of 20 reactions 
of allergic contact dermatitis studied at  72  h.  In this group,  Fib was  absent 
from the reticular dermis only in weak reactions elicited with formalin and in 
the single case of kerosine allergy studied; in the latter instance, however, Fib 
was found in the papillary dermis. With regard to delayed reactions elicited by 
intradermal injection of  protein antigens, Fib deposits  were  detected  in  the 
reticular dermis in all of 20 positive lesions studied at 48 h  (50T;  7 Candida; 
3 SK/SD; and 5 mumps). 
The  time-course of  Fib accumulation was  studied  in serial biopsies  taken 692  FIBRIN  DEPOSITION  LN  DELAYED  SKIN  REACTIONS  IN  1VL~.N 
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FIG. 5. Schematic diagram illustrating the distribution of Fib deposits in the lesions of 
alIergic contact dermatitis and delayed hypersensitivity to intradermal antigens as detected 
both by immunofluorescence  and by the 1 tim Epon techniques. 
from volunteers sensitized and tested with DNCB (Table I). In 8 of 12  biopsies 
taken at 4 and 8 h  after application of DNCB, isolated, focal deposits of Fib 
were  seen,  particularly  around  dermal  appendages  and  occasionally  in  the 
papillary dermis. By 24 h  Fib deposits had increased markedly and often ex- 
tended throughout the upper reticular dermis. MaximM amounts of Fib were 
observed at 24-72 h, but even at 6 and 11 days after testing Fib was generally 
still detectable in the reticular dermis. 
A  striking  feature of these  reactions was  the  absence of detectable  Fib in 
blood vessel walls. Such vascular wall deposition is characteristic of antibody- 
mediated  reactions of the Arthus  type  (13-16).  In only two instances out of 
94 biopsies studied  was significant vascular staining  (1+) present in addition 
to intervascular Fib accumulation (one 24 h DNCB and one 72 h 1,4-benzenedi- 
amine contact  reaction).  In the  latter instance,  vessels positive for Fib were 
also stained by antisera with specificity for IgM, IgA, and C'3, and Epon sec- 
tions revealed intravascular accumulations of neutrophils, suggesting an Arthus 
component. In an additional six biopsies faint Fib deposits were found in rare 
vessel walls, but the significance of these is uncertain. 
Immuno//uorescence: lmmunoglobulins,  C'3, and HSA.--No specific deposits 
of IgG, IgM, IgA, IgE, C'3, or HSA could be detected by immunofluorescence COLVIN, JOHNSON, MIHM, AND  DVORAK 
in the skin test sites, aside from the single exception noted above. Nonspecific 
staining of the cytoplasm of occasional epidermal cells and the lining of vesicles 
in contact lesions  and va6able staining of granulocytes (17) occurred with all 
fluoresceinated  antisera  used  including  antirabbit  IgG.  Occasional  dead  or 
damaged epidermal cells were observed in 1 #m Epon sections in these reactions, 
and it is likely that the nonspecific epidermal staining was related to cell injury 
(18). 
Controls.--12  biopsies  of  48-h  DNCB  Skin  test  sites  in  unsensitized  in- 
dividuals, 5 biopsies of negative skin reactions to protein antigens, 4 biopsies 
of 48-h saline test sites, and 7 biopsies of normal skin were studied (Tables I 
and  II).  Control  DNCB  test  sites  lacked  erythema  and  Fib  deposits  but 
regularly exhibited  a  mild perivascular  mononuclear cell  infiltrate in  Epon 
sections. Four of five "negative" intradermal test sites exhibited erythema (up 
to 7 mm diameter) and mild induration and all exhibited a mononuclear in- 
filtrate; Fib deposits were found in two of these biopsies.  Saline skin test sites 
and normal skin were negative by gross, microscopic, and fluorescent antibody 
criteria. 
DISCUSSION 
The data presented here indicate that extensive extravascular dermal de- 
posits of fibrin are a distinctive and consistent feature of delayed hypersensi- 
tivity skin  reactions in  man  and identify the  fibrillar material  observed  in 
Epon-embedded, light microscopic sections of these reactions as fibrin. That the 
Fib  detected was  not unpolymerized fibrinogen is  indicated by its  fibrillar 
appearance and by its characteristic periodicity (19) in the electron microscope 
(A.  M.  Dvorak,  unpublished  data).  The  distribution of fibrin  deposition-- 
principally in the intervascular portions of the reticular dermis with sparing 
of vessels  and the immediate perivascular space---is  quite different from that 
described in antibody-mediated lesions in animals or man (13-15). These find- 
ings provide convincing direct evidence for activation of the coagulation system 
in the course of delayed reactions and complement earlier studies that demon- 
strated inhibition of cellular hypersensitivity by anticoagulants (1-7). 
Previous limited immunofluorescence studies of delayed reactions have pre- 
sented a confusing picture. Paronetto et al., in a preliminary investigation of 
guinea pig (14) and human (13) tuberculin reactions~ reported fibrin deposits in 
and around blood vessel walls,  in a  similar distribution to  that observed  in 
Arthus reactions (14) and in vasculitis (13-16). In contrast, our own data on a 
large series  of patients indicate that vascular and perivascular localization of 
fibrin is extremely rare (2 of 94 biopsies), whereas intervascular fibrin deposits, 
removed from vessels and their surrounding cuffs of lymphocytes, were identi- 
fied in  almost every reaction studied at  the peak  of its intensity (55  of 58 
biopsies). In one of the two exceptional cases exhibiting significant fibrin de- 
posits in blood vessel walls we also found deposits of immunoglobulin and C'3 694  FIBRIN  DEPOSITION  IN  DELAYED  SKIN  REACTIONS  IN  MAN 
in a similar distribution. Aside from this single case, and in general agreement 
with most other workers, immunoglobutin and C'3 deposits were not found in 
these delayed reactions (13, 14, 20). We conclude that vessel-associated deposits 
of fibrin are not an intrinsic part of cellular hypersensitivity but rather reflect 
activation  of  the  clotting  system  secondary  either  to  nonspecific  vascular 
damage or to the presence of a complicating Arthus component. 
The pathogenesis of fibrin deposition in delayed hypersensitivity reactions is 
not yet clear. Fibrin is ultimately derived from circulating fibrinogen, and its 
accumulation in delayed skin reactions provides evidence for locally increased 
vascular  permeability  (21),  particularly  involving  the  vessels  of  the  upper 
reticular dermis where Fib  deposition is most prominent. In fact, fibrinogen 
may provide an unusually sensitive measure of altered vascular permeability 
since, unlike other plasma proteins that contribute to the extracellular fluid, it 
may polymerize under appropriate circumstances to form an insoluble product 
that  serves as an enduring permeability indicator. The characteristic pattern 
of fibrin deposition in the intervascular portions of the upper reticular dermis 
is unusual and, to our knowledge, has not yet been described in other skin dis- 
orders (16, 22-25). 
Polymerization of extravascular fibrinogen in  delayed hypersensitivity re- 
actions could be initiated in several ways that might involve either the intrinsic 
or extrinsic coagulation pathways. That fibrin deposition is not simply a con- 
sequence of tissue injury (such as trauma from intradermal skin testing, biopsy 
artifact, or severe reactions with  associated necrosis) is indicated  1--  by its 
deposition  in  allergic  contact  dermatitis  after  epicutaneous  application  of 
allergen; 2--  by its appearance as early as 4-8 h after testing with DNCB in a 
majority of sensitized subjects (Table I); 3--  by its absence from a variety of 
control test sites (Tables I  and n). The distinctive anatomic associations be- 
tween fibrin and elastic fibers and collagen suggest that these may have a role 
in initiating the clotting sequence, and such a role has in fact been claimed for 
collagen  (26,  27).  It  is  possible,  therefore,  that  fibrin deposition in  delayed 
hypersensitivity  is  merely  a  necessary  consequence  of  enhanced  vascular 
permeability that  allows  increased leakage of fibrinogen into  the  interstitial 
space  where  connective  tissue  elements  initiate  clotting.  Alternatively,  co- 
agulation could be triggered by a  product of sensitized lymphocytes (28), or 
these  cells  could  exert  their  effect less  directly,  as  by interfering with  the 
fibrinolytic mechanism. Relevant to these hypotheses is the demonstration that 
fibrinolytic activity is concentrated about small  cutaneous blood vessels  (29, 
30); that a number of inflammatory reactions of the skin are characterized by a 
measurable  reduction  in  vessel-associated fibrinolytic activity  (20,  31);  and 
that fibrin deposits spare those portions of the dermis (the perivascular zones) 
where lymphocytes, the fibrinolytic mechanism, and presumably fibrinogen are 
present  in  highest  concentration.  The  possibility  of  an  antibody-mediated 
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the absence of detectable immunoglobulins and the observed pattern of fibrin 
distribution argue against it. Moreover, similar fibrin deposits have been found 
in delayed reactions in guinea pigs sensitized so as to avoid antibody production 
(R. B. Colvin and H. F. Dvorak, unpublished data). 
The significance of fibrin deposition in delayed-type hypersensitivity is un- 
certain, but fibrin could contribute to the pathogenesis of these reactions in at 
least two ways. On the one hand, initiation of clotting by thrombin involves 
the splitting off of two small bioactive peptides from fibrinogen monomer (31) 
and subsequent  limited proteolysis of fibrinogen or fibrin by plasmin yields 
other biologically potent fragments (31). The phalmacologic properties of these 
fibrinogen/fibrin derivatives  are  as  yet poorly characterized,  particularly in 
man, but include potentiation of bradykinin-induced smooth muscle contraction 
(32), increased vascular permeability (33, 34),  and chemotaxis of granulocytes 
(35, 36).  Finally, insertion of a loose meshwork of long chain, insoluble fibrin 
polymer into the connective tissue matrix could lead to an expansion of the 
extravascular space with accumulation of water and plasma proteins. This, in 
turn, could explain the "swollen" appearance of the dermal collagen in delayed 
reactions studied with conventional histologic methods in which delicate fibrin 
strands may be difficult to visualize against a  background of dense collagen 
fibers (37).  Such accumulations of fluid might contribute significantly to the 
induration that is a characteristic feature of delayed hypersensitivity reactions. 
SUMMARY 
The  expression  of  delayed-type hypersensitivity in  animals  has  been  in- 
hibited by a  variety of anticoagulants, but direct evidence for activation of 
clotting in the evolution of these reactions has been lacking. Using the fluores- 
cent antibody technique we here demonstrate that fibrin deposition is a prom- 
inent  and  consistent feature  of both  allergic  contact dermatitis  and  classic 
delayed hypersensitivity skin reactions in man. Fib was detected in 55 of 58 
delayed reactions studied at  the peak  of their intensity. The  characteristic 
distribution of Fib--principally in the intervascular portions of the reticular 
dermis  with  sparing  of  vessels  and  their  associated  cuffs  of  mononuclear 
cells--is unusual and quite different from that described in antibody-mediated 
lesions in animals or man. Fib was found in vessel walls in only 2 of 94 biopsies 
studied. With a  single exception, deposition of immunoglobulins and comple- 
ment was not observed. 
The pathogensis and significance of Fib deposition in these reactions are not 
yet clear. Fib is ultimately derived from circulating fibrinogen, and its accumu- 
lation provides additional evidence for locally increased vascular permeability 
in delayed hypersensitivity. Polymerization of extravascular fibrinogen could 
be triggered nonspecifically by dermal elements (e.g., collagen) or by a product 
of sensitized lymphocytes. The appearance of Fib early in the development of 
these  reactions  (4-8  h  after  epicutaneous  test  with DNCB)  and  inhibition 696  FIBRIN  DEPOSITION  IN  DELAYED  SKIN  REACTIONS  IN  MAN 
studies with anticoagulants together suggest  that clotting may have a  role in 
their pathogenesis, possibly by the release of bioactive peptides from fibrinogen/ 
fibrin  or  by  contributing  to  the  induration  characteristic  of  delayed hyper- 
sensitivity. 
The authors gratefully acknowledge the expert technical assistance of Eleanor J. Manseau. 
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